Free Trial

Bristol-Myers Squibb (BMY) News Today

Bristol-Myers Squibb logo
$56.39 -0.81 (-1.42%)
As of 10:19 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Bristol-Myers Squibb stock logo
Cinctive Capital Management LP Sells 60,105 Shares of Bristol-Myers Squibb (NYSE:BMY)
Cinctive Capital Management LP trimmed its stake in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 20.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 228,343 shares of the biopharmaceutica
Bristol-Myers Squibb stock logo
Bristol-Myers Squibb (NYSE:BMY) Position Raised by Meeder Advisory Services Inc.
Meeder Advisory Services Inc. increased its holdings in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 29.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 34,845 shares of the biopharmaceutical c
Bristol-Myers Squibb stock logo
Meeder Asset Management Inc. Has $31,000 Stake in Bristol-Myers Squibb (NYSE:BMY)
Meeder Asset Management Inc. cut its stake in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 98.3% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 541 shares of the biopharmaceutical company's stock after sellin
Bristol-Myers Squibb stock logo
Te Ahumairangi Investment Management Ltd Has $4.14 Million Stake in Bristol-Myers Squibb (NYSE:BMY)
Te Ahumairangi Investment Management Ltd lowered its stake in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 32.9% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 73,144 shares o
Bristol-Myers Squibb stock logo
Zacks Research Has Bearish Forecast for BMY Q1 Earnings
Bristol-Myers Squibb (NYSE:BMY - Free Report) - Zacks Research lowered their Q1 2027 earnings estimates for Bristol-Myers Squibb in a note issued to investors on Tuesday, April 1st. Zacks Research analyst E. Bagri now forecasts that the biopharmaceutical company will earn $1.34 per share for the
Bristol-Myers Squibb stock logo
Bristol-Myers Squibb (NYSE:BMY) Shares Sold by Groupama Asset Managment
Groupama Asset Managment lessened its holdings in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 25.5% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 47,371 shares of the biopharmaceutical company's stock after selling 16,
Bristol-Myers Squibb stock logo
Diametric Capital LP Invests $296,000 in Bristol-Myers Squibb (NYSE:BMY)
Diametric Capital LP acquired a new stake in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 5,240 shares of the biopharmaceutical company's stock, value
Bristol-Myers Squibb stock logo
Tradewinds LLC. Makes New $283,000 Investment in Bristol-Myers Squibb (NYSE:BMY)
Tradewinds LLC. acquired a new stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 5,042 shares of the biopharmaceutical company's stock, valued at approximately $283,
Bristol-Myers Squibb stock logo
Bristol-Myers Squibb (NYSE:BMY) Shares Sold by Franklin Resources Inc.
Franklin Resources Inc. decreased its position in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 2.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,472,488 shares of the biopharmaceutical company
Bristol-Myers Squibb stock logo
Bristol-Myers Squibb (NYSE:BMY) Shares Sold by Alliancebernstein L.P.
Alliancebernstein L.P. decreased its holdings in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 9.8% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 3,524,406 shares of the biopharmaceutical company's stock after selling 3
Bristol-Myers Squibb stock logo
Wellington Management Group LLP Boosts Stock Position in Bristol-Myers Squibb (NYSE:BMY)
Wellington Management Group LLP grew its position in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 3,880.0% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 5,977,505 shares of the biopharmaceutical company's stock after buying an
Zacks Research Analysts Reduce Earnings Estimates for BMY
Bristol-Myers Squibb stock logo
Bristol-Myers Squibb (NYSE:BMY) Shares Acquired by Geode Capital Management LLC
Geode Capital Management LLC boosted its holdings in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 2.7% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 44,391,247 shares of the biopharmaceutical company's stock after acquiring an a
Bristol-Myers Squibb stock logo
National Wealth Management Group LLC Takes $255,000 Position in Bristol-Myers Squibb (NYSE:BMY)
National Wealth Management Group LLC purchased a new position in Bristol-Myers Squibb (NYSE:BMY - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 4,512 shares of the biophar
Bristol-Myers Squibb stock logo
National Bank of Canada FI Acquires 118,268 Shares of Bristol-Myers Squibb (NYSE:BMY)
National Bank of Canada FI lifted its holdings in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 4.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,625,009 shares of the biopharmaceutical company's
Bristol-Myers Squibb stock logo
CIBC Private Wealth Group LLC Grows Stake in Bristol-Myers Squibb (NYSE:BMY)
CIBC Private Wealth Group LLC boosted its holdings in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 3.7% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 307,582 shares of the biopharmaceutical company's stock after buying an additional 11,0
Bristol-Myers Squibb stock logo
HighPoint Advisor Group LLC Buys 4,160 Shares of Bristol-Myers Squibb (NYSE:BMY)
HighPoint Advisor Group LLC grew its position in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 7.3% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 60,927 shares of the biopharmaceutical company's stock after purchasing an additio
Bristol-Myers Squibb stock logo
Colrain Capital LLC Buys New Shares in Bristol-Myers Squibb (NYSE:BMY)
Colrain Capital LLC acquired a new position in Bristol-Myers Squibb (NYSE:BMY - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 121,500 shares of the biopharmaceutical company's stock, value
Bristol-Myers Squibb stock logo
Bristol-Myers Squibb (NYSE:BMY) Position Boosted by Edmond DE Rothschild Holding S.A.
Edmond DE Rothschild Holding S.A. lifted its stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 12.5% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 266,859 shares of the biopharmaceutical co
Bristol-Myers Squibb stock logo
O Shaughnessy Asset Management LLC Purchases 61,998 Shares of Bristol-Myers Squibb (NYSE:BMY)
O Shaughnessy Asset Management LLC grew its holdings in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 11.2% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 613,378 shares of the biopharmaceutical company's stock
Bristol-Myers Squibb stock logo
Bcwm LLC Invests $6.24 Million in Bristol-Myers Squibb (NYSE:BMY)
Bcwm LLC acquired a new stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 110,279 shares of the biopharmaceutical company's stock, valued at approximately $
Bristol-Myers Squibb stock logo
Brandywine Global Investment Management LLC Reduces Stock Holdings in Bristol-Myers Squibb (NYSE:BMY)
Brandywine Global Investment Management LLC reduced its stake in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 21.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 947,523 shares of the bioph
Bristol-Myers Squibb stock logo
Bristol-Myers Squibb (NYSE:BMY) Shares Sold by California Public Employees Retirement System
California Public Employees Retirement System cut its stake in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 21.9% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 6,505,730 shares of the biopharmaceutical
Bristol-Myers Squibb stock logo
Summit Securities Group LLC Has $2.92 Million Holdings in Bristol-Myers Squibb (NYSE:BMY)
Summit Securities Group LLC grew its stake in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 1,968.0% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 51,700 shares of the biopharmaceutical company's stock after purchasing an add
Bristol-Myers Squibb stock logo
Bristol-Myers Squibb (NYSE:BMY) Shares Bought by Schroder Investment Management Group
Schroder Investment Management Group increased its holdings in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 49.7% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,413,428 shares of the biopharm
Bristol-Myers Squibb stock logo
Allianz SE Invests $5.68 Million in Bristol-Myers Squibb (NYSE:BMY)
Allianz SE bought a new stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 101,287 shares of the biopharmaceutical company's stock, valued at appr
Bristol-Myers Squibb stock logo
Allstate Corp Acquires Shares of 60,310 Bristol-Myers Squibb (NYSE:BMY)
Allstate Corp bought a new position in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 60,310 shares of the biopharmaceutical company's stock, valued at
Bristol-Myers Squibb stock logo
Brown Brothers Harriman & Co. Sells 5,597 Shares of Bristol-Myers Squibb (NYSE:BMY)
Brown Brothers Harriman & Co. lessened its stake in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 6.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 80,832 shares of the biopharmaceutical company's stock after selling 5,
Bristol-Myers Squibb stock logo
Pictet Asset Management Holding SA Grows Holdings in Bristol-Myers Squibb (NYSE:BMY)
Pictet Asset Management Holding SA raised its stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 14.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,295,890 shares of the biopharmaceutical company's stock af
Bristol-Myers Squibb stock logo
Bristol-Myers Squibb (NYSE:BMY) Shares Purchased by Tucker Asset Management LLC
Tucker Asset Management LLC grew its stake in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 3,313.6% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 4,779 shares of the biopharmaceutical company's stock after acquiring an additional 4,639 shares
Bristol-Myers Squibb stock logo
Intrust Bank NA Buys 8,894 Shares of Bristol-Myers Squibb (NYSE:BMY)
Intrust Bank NA increased its stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 38.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 31,791 shares of the biopharmaceutical company's stock after acquir
Bristol-Myers Squibb stock logo
Loomis Sayles & Co. L P Sells 32,431 Shares of Bristol-Myers Squibb (NYSE:BMY)
Loomis Sayles & Co. L P decreased its position in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 11.7% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 245,168 shares of the biopharmaceutical company's stock after selling 32,431 shares
Bristol-Myers Squibb stock logo
DnB Asset Management AS Acquires 227,521 Shares of Bristol-Myers Squibb (NYSE:BMY)
DnB Asset Management AS increased its holdings in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 47.2% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 709,131 shares of the biopharmaceutical company's stock a
Bristol-Myers Squibb stock logo
Slagle Financial LLC Cuts Position in Bristol-Myers Squibb (NYSE:BMY)
Slagle Financial LLC decreased its stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 66.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 16,326 shares of the biopharmaceutical company's stock after selling
Bristol-Myers Squibb stock logo
Premier Fund Managers Ltd Purchases 16,100 Shares of Bristol-Myers Squibb (NYSE:BMY)
Premier Fund Managers Ltd boosted its stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 9.5% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 186,300 shares of the biopharmaceutical company's stock after buying an additio
Bristol-Myers Squibb stock logo
denkapparat Operations GmbH Invests $834,000 in Bristol-Myers Squibb (NYSE:BMY)
denkapparat Operations GmbH bought a new stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 14,748 shares of the biopharmaceutical company's stock
Bristol-Myers Squibb stock logo
Nomura Asset Management Co. Ltd. Trims Position in Bristol-Myers Squibb (NYSE:BMY)
Nomura Asset Management Co. Ltd. reduced its holdings in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 1.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,264,072 shares of the biopharmaceutical company's stock afte
Bristol-Myers Squibb stock logo
New Age Alpha Advisors LLC Invests $7.11 Million in Bristol-Myers Squibb (NYSE:BMY)
New Age Alpha Advisors LLC bought a new position in Bristol-Myers Squibb (NYSE:BMY - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 125,719 shares of the biopharmaceutical company's stock, valued at appr
Remove Ads
Get Bristol-Myers Squibb News Delivered to You Automatically

Sign up to receive the latest news and ratings for BMY and its competitors with MarketBeat's FREE daily newsletter.

BMY Media Mentions By Week

BMY Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BMY
News Sentiment

1.27

0.61

Average
Medical
News Sentiment

BMY News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BMY Articles
This Week

64

34

BMY Articles
Average Week

Remove Ads
Get Bristol-Myers Squibb News Delivered to You Automatically

Sign up to receive the latest news and ratings for BMY and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NYSE:BMY) was last updated on 4/4/2025 by MarketBeat.com Staff
From Our Partners